1,6-Dimethoxyhexane

1,6-Dimethoxyhexane 是一种脂肪族醚,可作为 PROTAC linker 和燃料添加剂,也是一种口服有效的睾丸毒性物质,其本身无直接毒性,但经肝脏/睾丸微粒体氧化代谢生成 2-甲氧基乙酸 (2-Methoxyacetic Acid, MAA) 后发挥毒性,可诱导粗线期精母细胞凋亡 (apoptosis)/坏死,并下调 HSP70.2、HSP60 和 ERp60/PDI A3 的表达,导致生精小管退化、睾丸/胸腺萎缩、附睾精子密度骤降等,可用于睾丸毒性相关研究。
产品编号: MS-G17080 CAS No.: 13179-98-1 分子式: C8H18O2 分子量: 146.23
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
250mg
询价
3-5 天
500mg
询价
3-5 天
1g
询价
3-5 天
5g
询价
询价
10g
询价
询价
50g
询价
询价

产品描述

1,6-Dimethoxyhexane 是一种脂肪族醚,可作为 PROTAC linker 和燃料添加剂,也是一种口服有效的睾丸毒性物质,其本身无直接毒性,但经肝脏/睾丸微粒体氧化代谢生成 2-甲氧基乙酸 (2-Methoxyacetic Acid, MAA) 后发挥毒性,可诱导粗线期精母细胞凋亡 (apoptosis)/坏死,并下调 HSP70.2、HSP60 和 ERp60/PDI A3 的表达,导致生精小管退化、睾丸/胸腺萎缩、附睾精子密度骤降等,可用于睾丸毒性相关研究。

生物实验数据

生物活性 1,6-Dimethoxyhexane is an aliphatic ether that can serve as a PROTAC linker and fuel additive, and is an orally effective testicular toxicant that exerts no direct toxicity itself but becomes toxic after oxidative metabolism by liver/testicular microsomes to 2-Methoxyacetic Acid (MAA); it can induce apoptosis/necrosis of pachytene spermatocytes and downregulate the expression of HSP70.2, HSP60, and ERp60/PDI A3, leading to degeneration of seminiferous tubules, testicular/thymic atrophy, and a sharp decrease in epididymal sperm density, and can be used for research related to testicular toxicity.
体内研究
(In Vivo)

1,6-Dimethoxyhexane (200 mg/kg;口服;每周 5 天;持续 4 周) 可诱导雄性 Sprague-Dawley 大鼠产生睾丸毒性,表现为 HSP70.2、HSP60 和 ERp60 蛋白显著下调,同时伴有其他差异表达的睾丸蛋白。
1,6-Dimethoxyhexane (200 mg/kg;口服;每周 5 天;连续 4 周) 可在雄性 Sprague-Dawley 大鼠中引发显著的睾丸毒性和胸腺毒性,同时伴随肝脏、甲状腺和骨髓的适应性改变,且血浆及尿液中 MAA 水平升高与毒性严重程度相关。

Animal Model: Sprague-Dawley (7-week-old male)
Dosage: 200 mg/kg
Administration: p.o.; 5 days per week; 4 weeks
Result: Downregulated heat shock-related 70 kDa protein 2 (HSP70.2) spots by 2.1-fold and 4.2-fold.
Downregulated 60 kDa heat shock protein mitochondrial precursor (HSP60) by 2.8-fold.
Downregulated protein disulfide-isomerase A3 precursor (ERp60) by 2.0-fold.
Upregulated an unidentified 47 kDa protein by 2.8-fold.
Downregulated an unidentified 41 kDa protein by 2.3-fold.
Upregulated an unidentified 38 kDa protein by 2.6-fold.
Downregulated an unidentified 37 kDa protein by 3.5-fold.
All significant changes showed greater than two-fold variation relative to controls with p < 0.05.
Animal Model: Sprague-Dawley (male, 7-week-old, 280 g)
Dosage: 200 mg/kg
Administration: p.o.; 5 days per week; 4 weeks
Result: Reduced feed consumption by 20% relative to controls.
Reduced final mean body weight by 17% relative to controls.
Lowered relative thymus weight by 48% relative to controls.
Lowered relative testis weight by 21% relative to controls.
Increased urinary creatine/creatinine molar ratio to 11-fold higher than controls.
Increased hepatic BROD activity to 0.117 nmol/min/mg prot relative to control 0.048 nmol/min/mg prot.
Increased hepatic UDPGT activity to 1.54 nmol/min/mg prot relative to control 1.03 nmol/min/mg prot.
Increased hepatic GST activity to 2.75 μmol/min/mg prot relative to control 1.87 μmol/min/mg prot.
Elevated urinary ascorbic acid levels significantly relative to controls.
Reduced liver thiobarbituric acid-reactive substances (TBARS) to 45% of control levels.
Decreased serum TBARS significantly relative to controls.
Increased urinary 2-methoxyacetic acid (MAA) levels to 6.4 times higher than controls.
Achieved a mean plasma MAA concentration of 0.34 mM.
Induced moderate degeneration of seminiferous tubules, interstitial vacuolation in testes, moderate to severe reduction in sperm density in the epididymis tail, presence of spermatid giant cells and cell debris in the epididymis, reduced cortical and medullary volume in the thymus, mild dyserythropoiesis and dysthrombopoiesis in bone marrow, mild thyroid changes, and mild adaptive histological changes in the liver.
性状 液体

化学信息

分子量 146.23
分子式 C8H18O2
CAS No. 13179-98-1

储存&溶解度

储存方式

Store at room temperature 3 years

In solvent -80°C 2 years
-20°C 1 year
运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础